Slow & Steady

The Slow & Steady portfolio delivers targeted exposure to high-potential healthcare stocks like Cybin Inc (CYBN), positioning investors for meaningful gains amid the 2026 market outlook. With a concentrated allocation in this innovative biotech name focused on mental health treatments, the strategy emphasizes growth stocks in the healthcare sector over broad diversification, offering a compelling sector ETF alternative for those seeking alpha. At 100% in CYBN, it blends healthcare and energy themes to capture emerging opportunities in undervalued stocks with strong clinical pipelines. Ideal for passive income seekers and retirement portfolio builders who prioritize long-term compounding, this approach suits beginner investors comfortable with sector bets rather than aggressive growth tactics. Key considerations include elevated volatility from single-stock concentration, regulatory risks in psychedelic medicine, and broader healthcare sector headwinds like policy shifts or clinical trial outcomes that could impact current valuation in Q1 2026.